Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Although central nervous system–resident microglia are believed to be ineffective at phagocytosing and clearing amyloid-β (Aβ), a major pathological hallmark of Alzheimer’s disease (AD), it has been suggested that peripheral myeloid cells constitute a heterogeneous cell population with greater Aβ-clearing capabilities. Here, we demonstrate that the conditional ablation of resident microglia in CD11b-HSVTK (TK) mice is followed by a rapid repopulation of the brain by peripherally derived myeloid cells. We used this system to directly assess the ability of peripheral macrophages to reduce Aβ plaque pathology and therefore depleted and replaced the pool of resident microglia with peripherally derived myeloid cells in Aβ-carrying APPPS1 mice crossed to TK mice (APPPS1;TK). Despite a nearly complete exchange of resident microglia with peripheral myeloid cells, there was no significant change in Aβ burden or APP processing in APPPS1;TK mice. Importantly, however, newly recruited peripheral myeloid cells failed to cluster around Aβ deposits. Even additional anti-Aβ antibody treatment aimed at engaging myeloid cells with amyloid plaques neither directed peripherally derived myeloid cells to amyloid plaques nor altered Aβ burden. These data demonstrate that mere recruitment of peripheral myeloid cells to the brain is insufficient in substantially clearing Aβ burden and suggest that specific additional triggers appear to be required to exploit the full potential of myeloid cell–based therapies for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“two recent studies showed that brain-engrafted bone marrow–derived cells either do not acquire microglial functions or do so only after a long time (202, 203).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [203]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with several studies showing that recruited myeloid cells are not as competent at restricting fAβ as resident microglia [48–50].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“in a transgenic CD11b-HSVTK mouse model, in which ganciclovir administration “paralyses” CD11b+ cells including microglia (i.e., where proliferation and activation is blocked), engrafted BM-derived monocytes failed to accumulate around Aβ plaques and did not reduce Aβ plaque burden [262]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [262]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“Interestingly, Trem2, a gene recently identified as a risk factor for AD (Guerreiro et al., 2013; Jonsson et al., 2013), also remained unchanged upon peripheral macrophage infiltration, suggesting that both resident microglia and peripheral myeloid cells can contribute to TREM2 protein expression…”
BackgroundNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 1×
“In contrast, there are examples in which modulation of the microglia response toward A did have a major impact on disease progression (vom Berg et al., 2012; Heneka et al., 2013; Chakrabarty et al., 2015; Guillot-Sestier et al., 2015).”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Self-citationLocal self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643 · cited 2×
“1 c), we achieved the exchange of resident microglia in the TK myeloid cells can enter the central nervous system (CNS) under certain conditions (Ajami et al., 2007; Mildner et al., 2011) and contribute to the immune response toward A deposits (Stalder et al., 2005).”
BackgroundThe microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 2×
“In line with this notion, one has to keep in mind that previously published studies reporting effects of infiltrating macrophages on A pathology used genetic models to either prevent recruitment of peripheral myeloid cells, e.g., by deficiency in CCR2 (Mildner et al., 2011; Naert and Rivest, 2011),…”
BackgroundResultKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986 · cited 2×
“To exchange the resident microglia pool with peripheral myeloid cells in an A-carrying AD-like mouse model, we generated APPPS1;TK+/ mice by crossing APPPS1 (Radde et al., 2006) to TK mice (Heppner et al., 2005).”
MethodExperimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 2×
“To exchange the resident microglia pool with peripheral myeloid cells in an A-carrying AD-like mouse model, we generated APPPS1;TK+/ mice by crossing APPPS1 (Radde et al., 2006) to TK mice (Heppner et al., 2005).”
MethodSelf-citation
Cited by
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Mrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I., Heppner, F. L., Kipnis, J., Merkler, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.011 · Cited by 1,010
“Also, during aging, inflammation in the brain gradually increases, a process termed ‘‘inflammaging’’ (Deleidi et al., 2015), and CNS leukocytes may also play a role in age-related inflammation and neurodegeneration (Baruch et al., 2013; Prokop et al., 2015; Ritzel et al., 2016).”
Self-citationFunctional morphology of the blood–brain barrier in health and disease
Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872
“However, more recent studies have challenged this view by showing that monocytes do not reduce the amyloid load, arguing against a role for circulating monocytes in Aβ clearance [97].”
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“Therefore, duringextravasation,leukocytes need to express glycosidases and proteases allowing them to degrade the basement membrane molecules (Yadav et al., 2003; Vreys and David, 2007; Wang et al., 2005; Reichel et al., 2008; Li and Vlodavsky, 2009; Voisin et al., 2009; Vestweber, 2015).”
InfluentialMicroglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza-Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 707
“For instance, Prokop et al. (2015), demonstrated that peripheral macrophages are insufficient to clear amyloid burden in APP/PS1 mice after BOX 1 | What can we do for better understanding of microglial phenotype in neuronal disorder?”
BackgroundNeuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
“However, a beneficial effect for monocyte infiltration has recently been challenged in the context of AD 382,383 .”
Herisson, F., Frodermann, V., Courties, G., Rohde, D., Sun, Y., Vandoorne, K., Wojtkiewicz, G. R., Masson, G. S., Vinegoni, C., Kim, J., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0213-2 · Cited by 610
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595
TREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440
“However, [542_TD$DIFF]can peripheral macrophages, if delivered into the brain or induced to enter the brain, clear toxic amyloid species more effectively thanmicroglia? Two research groups rigorously addressed this question using CD11b–HSVTK mice which express ganciclovir-sensitive thymidine kinase in all myeloid cell…”
BackgroundPeripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
Bettcher, B. M., Tansey, M. G., Dorothée, G., & Heneka, M. T. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00549-x · Cited by 427
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418
“Moreover, these myeloid cells fail to modify the Aβ load, despite adopting features of microglia (Prokop et al., 2015; Varvel et al., 2015).”
BackgroundBisht, K., Sharma, K., & Tremblay, M.-È. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.05.003 · Cited by 360
Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models
Spangenberg, E. E., & Green, K. N. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.003 · Cited by 352
“Assessment of the monocyte-repopulated brain revealed that the number of Ab deposits was unchanged (Prokop et al., 2015).”
BackgroundMyeloid Cells in the Central Nervous System
Herz, J., Filiano, A. J., Wiltbank, A. T., Yogev, N., & Kipnis, J. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.007 · Cited by 332
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
Bairamian, D., Sha, S., Rolhion, N., Sokol, H., Dorothée, G., Lemere, C. A., & Krantic, S. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00522-2 · Cited by 314
“In addition, peripheral inflammation contributes to AD progression and is correlated to cognitive deficits, specifically at MCI stage, and increased peripheral production of IL-1β and TNFα is associated with a higher risk of AD [69, 72].”
BackgroundElucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325
The identity and function of microglia in neurodegeneration
Song, W. M., & Colonna, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0212-1 · Cited by 308
Emerging roles of innate and adaptive immunity in Alzheimer’s disease
Chen, X., & Holtzman, D. M. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.016 · Cited by 297
Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
Zuroff, L., Daley, D., Black, K. L., & Koronyo-Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275
Resident and Monocyte-Derived Macrophages in Cardiovascular Disease
Honold, L., & Nahrendorf, M. (2018) · Circulation Research · doi:10.1161/circresaha.117.311071 · Cited by 274
“Likewise, depletion of microglia by intracerebroventricular administration of ganciclovir in mice expressing the herpes-simplex virus suicidegene thymidine kinase under the CD11b-promoter causes replenishment of microglia by monocyte-derived cells.(147,148) On the contrary, partial depletion of microglia in tamoxifen…”
To Kill a Microglia: A Case for CSF1R Inhibitors
Green, K. N., Crapser, J. D., & Hohsfield, L. A. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.001 · Cited by 262
Lund, H., Pieber, M., Parsa, R., Han, J., Grommisch, D., Ewing, E., Kular, L., Needhamsen, M., Espinosa, A., Nilsson, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07295-7 · Cited by 249
Unger, M. S., Li, E., Scharnagl, L., Poupardin, R., Altendorfer, B., Mrowetz, H., Hutter-Paier, B., Weiger, T. M., Heneka, M. T., Attems, J., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.070 · Cited by 248
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 233
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 244
“, where proliferation and activation is blocked), engrafted BM-derived monocytes failed to accumulate around Aβ plaques and did not reduce Aβ plaque burden [262].”
BackgroundPeripheral immune system in aging and Alzheimer’s disease
Cao, W., & Zheng, H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0284-2 · Cited by 214
Efficient Strategies for Microglia Replacement in the Central Nervous System
Xu, Z., Rao, Y., Huang, Y., Zhou, T., Feng, R., Xiong, S., Yuan, T.-F., Qin, S., Lu, Y., Zhou, X., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108041 · Cited by 172
NETosis in Alzheimer’s Disease
Pietronigro, E. C., Della Bianca, V., Zenaro, E., & Constantin, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00211 · Cited by 175
“However, the replacement of brain-resident myeloid cells with circulating peripheral monocytes in AD mouse models showed that monocyte repopulation does not modify the amyloid load, challenging the idea that peripheral monocytes play a role in Aβ clearance (28, 29).”
BackgroundYoung microglia restore amyloid plaque clearance of aged microglia
Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., Haass, C., & Tahirovic, S. (2017) · The EMBO Journal · doi:10.15252/embj.201694591 · Cited by 174
“However, microglial depletion experiments in AD mouse models argued against the role of myeloid cells in restricting plaque growth (Grathwohl et al , 2009; Prokop et al , 2015).”
Microglia versus Monocytes: Distinct Roles in Degenerative Diseases of the Retina
Yu, C., Roubeix, C., Sennlaub, F., & Saban, D. R. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.03.012 · Cited by 168
TREM2 Function in Alzheimer’s Disease and Neurodegeneration
Ulrich, J. D., & Holtzman, D. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00313 · Cited by 154
A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer’s models
Rentsendorj, A., Sheyn, J., Fuchs, D.-T., Daley, D., Salumbides, B. C., Schubloom, H. E., Hart, N. J., Li, S., Hayden, E. Y., Teplow, D. B., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.019 · Cited by 141
“…monocyte/macrophages on reducing cerebral Ab burden; however, these studies involved invasive techniques and/or compounds that depleted brain microglia (Prokop et al., 2015; Varvel et al., 2015), possibly eliminating the local signals to attract monocytes to Ab lesion sites (Shechter et al., 2009).”
BackgroundPiirainen, S., Youssef, A. M., Song, C., Kalueff, A. V., Landreth, G. E., Malm, T., & Tian, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.046 · Cited by 136
Differential contribution of microglia and monocytes in neurodegenerative diseases
Baufeld, C., O'Loughlin, E. K., Calcagno, N., Madore, C., & Butovsky, O. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 139
“The approach of a transient depletion of resident microglia using an inducible suicide gene and their subsequent replacement with peripheral myeloid cells did not have any impact on Ab plaque burden or APP processing (Prokop et al. 2015; Varvel et al. 2015).”
BackgroundInflammatory mechanisms in neurodegeneration
Nichols, M. R., St‐Pierre, M., Wendeln, A., Makoni, N. J., Gouwens, L. K., Garrad, E. C., Sohrabi, M., Neher, J. J., Tremblay, M., & Combs, C. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14674 · Cited by 133
“However, the resulting replacement of microglia with peripherally derived myeloid cells did not alter amyloid plaque load (Prokop et al. 2015; Varvel et al. 2015), suggesting that the impairment of microglial clearance function in AD cannot be rescued by the infiltration of peripheral cells, as these are exposed to th…”
BackgroundTargeting innate immunity for neurodegenerative disorders of the central nervous system
Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., Landreth, G., Lee, D. C., Low, D., Lynch, M. A., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13667 · Cited by 126
Unger, M. S., Schernthaner, P., Marschallinger, J., Mrowetz, H., & Aigner, L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1304-4 · Cited by 118
“amyloid clearance (reviewed in [28–30] and [61]).”
A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer’s disease
Yoo, Y., Neumayer, G., Shibuya, Y., Mader, M. M.-D., & Wernig, M. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.07.006 · Cited by 109
Möhle, L., Israel, N., Paarmann, K., Krohn, M., Pietkiewicz, S., Müller, A., Lavrik, I. N., Buguliskis, J. S., Schott, B. H., Schlüter, D., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0293-8 · Cited by 103
“depletion of brain resident CD11b-expressing cells during a 10 to 14 days intracerebral ganciclovir treatment of CD11b-HSVTK (herpes simplex virus thymidine kinase) transgenic mice [100, 101].”
BackgroundMethodSoluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
Bekris, L. M., Khrestian, M., Dyne, E., Shao, Y., Pillai, J. A., Rao, S. M., Bemiller, S. M., Lamb, B., Fernandez, H. H., & Leverenz, J. B. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.003 · Cited by 99
Varvel, N. H., Grathwohl, S. A., Degenhardt, K., Resch, C., Bosch, A., Jucker, M., & Neher, J. J. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150478 · Cited by 99
Scholtzova, H., Do, E., Dhakal, S., Sun, Y., Liu, S., Mehta, P. D., & Wisniewski, T. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1967-16.2016 · Cited by 82
“The dependence of this amyloid-clearance capacity on appropriate stimulation is consistent with observations that unstimulated peripheral myeloid cells are unable to reduce A related pathology in APP/PS1 AD mice (Prokop et al., 2015).”
ResultPeripheral and central neuroimmune mechanisms in Alzheimer’s disease pathogenesis
Zhang, S., Gao, Y., Zhao, Y., Huang, T. Y., Zheng, Q., & Wang, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00812-5 · Cited by 78
“Nonetheless, replacing brain-resident microglia with peripheral monocytes does not affect the amyloid plaque load in AD mouse models with amyloid pathology [63, 64].”
Zuo, Z., Qi, F., Yang, J., Wang, X., Wu, Y., Wen, Y., Yuan, Q., Zou, J., Guo, K., & Yao, Z. B. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.001 · Cited by 80
Rivera-Escalera, F., Pinney, J. J., Owlett, L., Ahmed, H., Thakar, J., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1645-7 · Cited by 75
Koronyo-Hamaoui, M., Sheyn, J., Hayden, E. Y., Li, S., Fuchs, D.-T., Regis, G. C., Lopes, D. H. J., Black, K. L., Bernstein, K. E., Teplow, D. B., et al. (2020) · Brain · doi:10.1093/brain/awz364 · Cited by 70
“…et al., 2015), though some studies have failed to show migration of these cells under neuro- degenerative conditions (Mildner et al., 2007), or showed monocyte migration to CNS without effects on behaviour and cerebral amyloid-b levels (Prokop et al., 2015; Varvel et al., 2015; Cronk et al., 2018).”
ResultThe role of the immune system in driving neuroinflammation
Ní Chasaide, C., & Lynch, M. A. (2020) · Brain and Neuroscience Advances · doi:10.1177/2398212819901082 · Cited by 72
“…beneficial and effective phagocytes, other data indicate that when microglia were replaced by peripheral myeloid cells, amyloid pathology was unchanged (Prokop et al., 2015; Varvel et al., 2015), although Ly6ClowCX3CR1highCCR2− monocytes can engulf Aβ in perivascular spaces (Michaud et al., 2013).”
BackgroundResultChen, Y., Lad, E. M., Mathew, R., Shiraki, N., Littleton, S., Chen, Y., Hou, J., Schlepckow, K., Degan, S., Chew, L. A., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231011 · Cited by 76
“…in producing these changes (Bennett et al., 2018; Reed-Geaghan et al., 2020; Shemer et al., 2018) since infiltrated monocyte-derived macrophages do not fully adopt the same characteristics (Ajami et al., 2011; Cronk et al., 2018; O ’ Koren et al., 2016; Prokop et al., 2015; Varvel et al., 2015).”
BackgroundMuñoz-Castro, C., Mejias-Ortega, M., Sanchez-Mejias, E., Navarro, V., Trujillo-Estrada, L., Jimenez, S., Garcia-Leon, J. A., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Romero-Molina, C., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01530-z · Cited by 66
“In fact, microglial depletion strategies induced a rapid repopulation by peripherally-derived macrophages [9, 21, 31, 41, 44, 58].”
BackgroundManji, Z., Rojas, A., Wang, W., Dingledine, R., Varvel, N. H., & Ganesh, T. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180678 · Cited by 60
“However, ablation of resident microglia and repopulation of brain with peripheral monocytes was not sufficient to clear amyloid load [35, 62].”
Yin, H., Ju, Z., Zheng, M., Zhang, X., Zuo, W., Wang, Y., Ding, X., Zhang, X., Peng, Y., Li, J., et al. (2023) · PLOS Biology · doi:10.1371/journal.pbio.3002017 · Cited by 62
The Functions and Phenotypes of Microglia in Alzheimer’s Disease
Fujikawa, R., & Tsuda, M. (2023) · Cells · doi:10.3390/cells12081207 · Cited by 47
“In addition, despite a nearly complete exchange of resident microglia with peripheral myeloid cells in CD11b-HSVTK mice, there was no significant change in Aβ burden or APP processing [84].”
BackgroundRecent advances in the understanding of microglial development and homeostasis
Low, D., & Ginhoux, F. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.004 · Cited by 63
Microglia, autonomic nervous system, immunity and hypertension: Is there a link?
Li, Y., Wei, B., Liu, X., Shen, X. Z., & Shi, P. D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104451 · Cited by 59
Contributions of monocytes to nervous system disorders
Garré, J. M., & Yang, G. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1672-3 · Cited by 57
“In Tg-AD mice depleted of resident microglia, the repopulated microglia in brain parenchyma do not affect Aβ clearance [42].”
Shi, M., Chu, F., Zhu, F., & Zhu, J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03003-5 · Cited by 54
“But, using brain-resident myeloid cells did not alter Aβ deposition in two mouse models of AD (APP23 and APP/PS1 mice) [101, 102], indicating that peripheral monocytes and microglia play their respective roles in clearing Aβ.”
BackgroundHohsfield, L. A., Najafi, A. R., Ghorbanian, Y., Soni, N., Crapser, J. D., Velez, D. X. F., Jiang, S., Royer, S. E., Kim, S. J., Henningfield, C. M., et al. (2021) · eLife · doi:10.7554/elife.66738 · Cited by 50
Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology
Zhang, Z., Takeda‐Uchimura, Y., Foyez, T., Ohtake‐Niimi, S., Narentuya, Akatsu, H., Nishitsuji, K., Michikawa, M., Wyss‐Coray, T., Kadomatsu, K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615036114 · Cited by 53
“By using genetic ablation systems in which peripherally derived myeloid cells are recruited and replaced with microglia in the AD brain, we may address the question of whether a subset of 5D4-KS cells resides in the brain (46, 47).”
BackgroundSelf-citationLi, S., Hayden, E. Y., Garcia, V. J., Fuchs, D.-T., Sheyn, J., Daley, D. A., Rentsendorj, A., Torbati, T., Black, K. L., Rutishauser, U., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00049 · Cited by 51
Kawanishi, S., Takata, K., Itezono, S., Nagayama, H., Konoya, S., Chisaki, Y., Toda, Y., Nakata, S., Yano, Y., Kitamura, Y., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170994 · Cited by 49
“Recent studies show that BM-derived cells can infiltrate the central nervous system and form microglia-like populations in irradiated [82] or microglia-depleted AD model mice [83], in mice after middle cerebral artery occlusion [84], and in embryonic microglia-depleted zebrafish [85].”
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 47
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
Patel, A. G., Nehete, P. N., Krivoshik, S. R., Pei, X., Cho, E. L., Nehete, B. P., Ramani, M. D., Shao, Y., Williams, L. E., Wisniewski, T., et al. (2021) · Brain · doi:10.1093/brain/awab129 · Cited by 44
Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids
Fiala, M., Kooij, G., Wagner, K., Hammock, B., & Pellegrini, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2844-6 · Cited by 42
Immune dysfunction in Alzheimer disease
Butovsky, O., Rosenzweig, N., Kleemann, K. L., Jorfi, M., Kuchroo, V. K., Tanzi, R. E., & Weiner, H. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00997-0 · Cited by 48
“For example, replacing microglia with bone marrow-derived monocytes did not alter Aβ plaque deposition in AD mice 93,94 , suggesting that an interplay between resident microglia and peripheral monocytes may be crucial for efficient Aβ plaque clearance.”
Regulation of Microglia Identity from an Epigenetic and Transcriptomic Point of View
Eggen, B. J. L., Boddeke, E. W. G. M., & Kooistra, S. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.010 · Cited by 34
Costello, D. A., Keenan, K., McManus, R. M., Falvey, A., & Lynch, M. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.001 · Cited by 33
“, 2005) although a recent study showed that replacement of microglia with peripheral myeloid cells did not enhance amyloid clearance (Prokop et al., 2015; Varvel et al., 2015), but Ly6CloCX3CR1highCCR2 monocytes engulfed perivascularly located Ab deposits, at least in young APP/PS1 mice (Michaud et al.”
Lemaître, P., Tareen, S. H. K., Pasciuto, E., Mascali, L. G., Martirosyan, A., Callaerts‐Vegh, Z., Poovathingal, S. K., Dooley, J., Holt, M. G., Yshii, L., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216805 · Cited by 35
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 28
“In subsequent studies, it was demonstrated that cessation of ganciclovir delivery resulted in complete exchange of the microglial pool by peripheral myeloid cells (Varvel et al., 2012, 2015; Prokop et al., 2015).”
BackgroundMethodTakatori, S., Kondo, M., & Tomita, T. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00383-4 · Cited by 29
Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
Rosa, F. L., Saresella, M., Baglio, F., Piancone, F., Marventano, I., Calabrese, E., Nemni, R., Ripamonti, E., Cabinio, M., & Clerici, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16754-y · Cited by 27
Kuroda, E., Nishimura, K., Kawanishi, S., Sueyoshi, M., Ueno, F., Toji, Y., Abo, N., Konishi, T., Harada, K., Satake, S., et al. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.004 · Cited by 24
The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia
Sirkis, D. W., Bonham, L. W., & Yokoyama, J. S. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s245029 · Cited by 18
Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 25
The Role of Microglial Depletion Approaches in Pathological Condition of CNS
Tahmasebi, F., & Barati, S. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01326-8 · Cited by 22
“A genetic system eliminates microglia by diphtheria toxin (DT) (Prokop et al. 2015).”
BackgroundNovel alterations in corneal neuroimmune phenotypes in mice with central nervous system tauopathy
Jiao, H., Downie, L. E., Huang, X., Wu, M., Oberrauch, S., Keenan, R. J., Jacobson, L. H., & Chinnery, H. R. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01803-7 · Cited by 20
“It is hypothesized that peripheral myeloid cells migrate to the CNS where they phagocytose tau aggregates or tau-laden neurons [87]; however, the contribution of peripheral myeloid cells to the pathogenesis of AD is still under debate.”
BackgroundThe Immune System as a Therapeutic Target for Alzheimer’s Disease
Zieneldien, T., Kim, J., Sawmiller, D. R., & Cao, C. (2022) · Life · doi:10.3390/life12091440 · Cited by 24
Kuroda, E., Takata, K., Nishimura, K., Oka, H., Sueyoshi, M., Aitani, M., Kouda, A., Satake, S., Shima, C., Toda, Y., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190974 · Cited by 20
Ye, X., Chen, J., Pan, J., Wu, Q., Wang, Y., Lu, M., Zhang, C., Zhang, Z., Ma, M., Zhu, J., et al. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2136525 · Cited by 18
“Instead, macrophages in the brain promote microglia activation and reduce synaptic plasticity (Barrett et al. 2015; Blau et al. 2012; Prokop et al. 2015; Varvel et al. 2015).”
BackgroundWang, Y., Jiang, R., Li, M., Wang, Z., Yang, Y., & Sun, L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230784 · Cited by 19
Neuroimmune interactions in Alzheimer's disease—New frontier with old challenges?
Prokop, S., Lee, V. M. ‐., & Trojanowski, J. Q. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.10.002 · Cited by 19
Self-citationBone Marrow‐Derived GCA+ Immune Cells Drive Alzheimer's Disease Progression
Zhou, R., Wang, L., Chen, L., Xu, F., Zhou, R., Peng, X. F., Wen, J., Huang, Y., & Zhou, H. (2023) · Advanced Science · doi:10.1002/advs.202303402 · Cited by 19
Neuroinflammation and Disease: Pathways and Opportunities
Hoffman, O., Varvel, N. H., Roopra, A., & Dingledine, R. J. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-043519 · Cited by 15
Liu, Z., Bai, Y.-D., Yu, Z., Li, H., Liu, J., Tan, C., Zeng, G., Tu, Y., Sun, P., Jia, Y., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01077-y · Cited by 18
“Previous studies have demonstrated that the recruitment of monocytes of young or WT mice into the AD brain is insufficient to substantially clear its Aβ burden due to the inflammatory microenvironment in the brain during AD [41, 42].”
BackgroundWang, X., Wang, D., Su, F., Li, C., & Chen, M. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-4974 · Cited by 26
“Neuroinflammation is not restricted to the microglia and astrocytes, which are the brain’s resident immune cells, but includes strong interactions with peripheral immune cells including neutrophils (12), macrophages (13), and lymphocytes (14).”
BackgroundMultitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 16
“Follow-up papers showed that even repopulation of the myeloid compartment with cells from the periphery failed to alter plaque levels (Prokop et al. 2015; Varvel et al. 2015) questioning the importance of a phagocytic deficit in propagation of AD pathology.”
BackgroundExploring microglial replacement: From disease models to clinical translation
Zhou, K., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.011 · Cited by 13
“Additional experimental paradigms utilizing genetically modified microglial depletion models, including CD11b-HSVTK (TK) mice (Varvel et al., 2015; Hepp-ner et al., 2005; Prokop et al., 2015); Cx3cr1 CreER/ + :Csf1r Flox/Flox mice (Cronk et al., 2018), and Cx3cr1 creERT2 x iDTR mice subjected to…”
Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options
Cooper, C. G., Kafetzis, K. N., Patabendige, A., & Tagalakis, A. D. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16229 · Cited by 11
Murray, P. J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.11.004 · Cited by 11
Advances in Clinical Mass Cytometry
Koladiya, A., & Davis, K. L. (2023) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2023.05.004 · Cited by 11
Yu, Z., Liu, J., Liu, Z., Liu, X., Tuo, J., Li, J., Tu, Y., Tan, Q., Ma, Y., Bai, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14402 · Cited by 13
“44,45 Furthermore, we found a faster decline in exogenously injected A β content after replacing the deficit BMCs. Theseabovefindingsindicatethatthemainactionsiteforbloodmono-cytes to clear A β is in the peripheral system.”
CNS myeloid cells critically regulate heat hyperalgesia
Kälin, S., Miller, K. R., Kälin, R. E., Jendrach, M., Witzel, C., & Heppner, F. L. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95305 · Cited by 10
Self-citationZheng, Y., Xu, W., Suo, Z., Qu, Y., Lin, L., Zhang, E., Han, D., Wu, M., Hongyi, L. I., Zheng, H., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03566-5 · Cited by 10
“Microglia replacement therapies have shown promising results in the treatment of neurodegenerative diseases [72, 73], and these approaches have been linked to potential toxicities or adverse effects, such as cytokine storms and astrocytic gliosis [74, 75].”
Peripheral macrophages not ADept at amyloid clearance
Jay, T. R., Lamb, B. T., & Landreth, G. E. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.21211insight5 · Cited by 6
van Gerresheim, E. F., Herring, A., Gremer, L., Müller‐Schiffmann, A., Keyvani, K., & Korth, C. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12685 · Cited by 7
“The contribution of microglia or myeloid cells to Aβ plaque load has also been emphasized (27).”
BackgroundThe Amyloid-beta rich CNS environment alters myeloid cell functionality independent of their origin
Drost, N., Houtman, J., Cseresnyés, Z., Niesner, R. A., Rinnenthal, J.-L., Miller, K. R., Prokop, S., & Heppner, F. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-63989-3 · Cited by 5
Self-citation
Metadata
- Authors
- Prokop, S., Miller, K. R., Drost, N., Handrick, S., Mathur, V., Luo, J., Wegner, A., Wyss-Coray, T., & Heppner, F. L.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- VA Palo Alto Health Care System (US)
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305 2
- NeuroCure Cluster of Excellence (DE)
- Corresponding author
- Heppner, Frank L.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-10-12
- Volume
- 212
- Issue
- 11
- Pages
- 1811-1818
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4612091
- OpenAlex
- W1922340941
- Cited by
- 116
- References
- 28
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 7 · 2021: 6 · 2020: 13 · 2019: 10 · 2018: 19 · 2017: 18 · 2016: 11 · 2015: 3
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Research Portal (King's College London) (acceptedVersion, cc-by-nc-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB TRR 43, NeuroCure EXC257, EXC257)
- Bundesministerium für Bildung und Forschung
- Berlin Institute of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- microglia, amyloid-beta clearance, Alzheimer's disease, APP/PS1 mice, myeloid cell recruitment, anti-amyloid antibodies, amyloid plaques, APP processing
- MeSH terms
- Alzheimer Disease, Animals, Cell Movement, Disease Models, Animal, Male, Vaccination, Ganciclovir, Amyloid beta-Peptides, Microglia, Myeloid Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.